Psychiatric Morbidity in Parkinson’s Disease: A Case Report
American Journal of Life Sciences
Volume 1, Issue 2, April 2013, Pages: 27-30
Received: Apr. 3, 2013; Published: Apr. 2, 2013
Views 2856      Downloads 115
Author
Amitabh Saha, Department of Psychiatry, Srinagar, Jammu & Kashmir, India
Article Tools
PDF
Follow on us
Abstract
Psychiatric disorders like anxiety and depression are common in patients with Parkinson’s disease. Patients are needed to be managed on a comprehensive basis, in which he can receive psychiatric management along with his medical advice and prescription. Parkinson’s disease is an illness affecting the geriatric age group resulting in debilitating and disfiguring disease associated with the presence of resting tremor, bradykinesia, and postural instability. The prevalence of social anxiety disorder in these patients is important, because further determines the improvement of the patient and his response to drugs.
Keywords
Parkinson’s Disease, Social Phobia, Anxiety Disorder, Debilitating Disorder, Depression, Bradykinesia, Antiparkinson’s Medications
To cite this article
Amitabh Saha, Psychiatric Morbidity in Parkinson’s Disease: A Case Report, American Journal of Life Sciences. Vol. 1, No. 2, 2013, pp. 27-30. doi: 10.11648/j.ajls.20130102.11
References
[1]
Reijnders JS, Ehrt U, Weber WE, et al: A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 2008; 23:183—189.
[2]
Lauterbach EC: The neuropsychiatry of Parkinson’s disease and related disorders. Psychiatr Clin North Am 2004; 27:801—825.
[3]
Nuti A, Ceravolo R, Piccinni A, et al: Psychiatric comorbidity in a population of Parkinson’s disease patients. Eur J Neurol 2004; 11:315—320.
[4]
Oberlander EL, Schneier FR, Liebowitz MR: Physical disability and social phobia. J Clin Psychopharmacol 1994; 14:136—143.
[5]
Stein MB, Baird A, Walker JR: Social phobia in adults with stuttering. Am J Psychiatry 1996; 153:278—280.
[6]
Devrimci-Özgüven H, Kudakçi N, Boyvat A: Secondary social anxiety in patients with psoriasis. Turk Psikiyatri Derg 2000; 11:121—126.
[7]
Gündel H, Wolf A, Xidara V, et al: Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry 2001; 71:499—504.
[8]
Schneier FR, Barnes LF, Albert SM, et al: Characteristics of social phobia among persons with essential tremor. J Clin Psychiatry 2001; 62:367—372.
[9]
Rosik CH: Psychiatric symptoms among prospective bariatric surgery patients: rates of prevalence and their relation to social desirability, pursuit of surgery, and follow-up attendance. Obes Surg 2005; 15:677—683.
[10]
Topcuoglu V, Bez Y, Sahin Bicer D, et al: Social phobia in essential tremor. Turk Psikiyatri Derg 2006; 17:93—100.
[11]
Ozel-Kizil ET, Akbostanci MC, Ozguven HD, et al: Secondary social anxiety in hyperkinesias. Mov Disord 2008; 23:641—645.
[12]
Yolaç Yarpuz A, Demirci Saadet E, Erdi Sanli H, et al: Social anxiety in acne vulgaris patients and relationship with clinical variables. Turk Psikiyatri Derg 2008; 19:29—37.
[13]
Ozel-Kizil ET: Social anxiety secondary to a general medical condition, in Social Phobia: Etiology, Diagnosis, and Treatment. Edited by Axelby CP. New York, Nova Publishers, 2009, pp 261—268.
[14]
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.
[15]
Stein MB, Heuser IJ, Juncos JL, et al: Anxiety disorders in patients with Parkinson’s disease. Am J Psychiatry 1990; 147:217—220.
[16]
de Rijk C, Bijl RV: Prevalence of mental disorders in persons with Parkinson’s disease. Ned Tijdschr Geneeskd 1998; 142:27—31.
[17]
Lauterbach EC, Freeman A, Vogel RL: Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2004; 16:29—36.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186